Abbott Laboratories

ABT | NYSE

Price Alert Chart Builder DCF Calculator

$108.63

+$2.43 (+2.29%)

Nov 2, 2026, 11:27 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023	Q3 2023 Sep 30, 2023	Q2 2023 Jun 30, 2023	Q1 2023 Mar 31, 2023	Q4 2022 Dec 31, 2022	Q3 2022 Sep 30, 2022	Q2 2022 Jun 30, 2022	Q1 2022 Mar 31, 2022	Q4 2021 Dec 31, 2021	Q3 2021 Sep 30, 2021	Q2 2021 Jun 30, 2021	Q1 2021 Mar 31, 2021
Revenue	13.01B	12.59B	11.16B	11.46B	11.37B	11.14B	10.36B	10.97B	10.64B	10.38B	9.96B	10.24B	10.14B	9.98B	9.75B	10.09B	10.41B	11.26B	11.9B	11.47B	10.93B	10.22B	10.46B
Cost of Revenue	5.59B	5.29B	4.88B	4.92B	5.03B	4.85B	4.91B	5.38B	5.21B	5.07B	4.94B	4.98B	5.11B	5.03B	4.94B	5.12B	5.2B	5.48B	5.53B	5.26B	4.87B	4.85B	4.89B
Gross Profit	7.42B	7.3B	6.28B	6.54B	6.34B	6.29B	5.44B	5.6B	5.43B	5.31B	5.02B	5.26B	5.03B	4.95B	4.81B	4.97B	5.21B	5.77B	6.37B	6.21B	6.06B	5.38B	5.57B
Operating Income	1.48B	1.78B	1.84B	2.25B	2.06B	2.05B	1.69B	1.99B	1.82B	1.69B	1.39B	1.86B	1.68B	1.51B	1.4B	1.44B	1.7B	2.33B	2.89B	2.45B	2.62B	2B	2.13B
Interest Income	n/a	n/a	106M	78M	77M	71M	82M	91M	91M	82M	80M	89M	97M	98M	101M	88M	55M	26M	14M	11M	10M	11M	11M
Pretax Income	1.23B	1.52B	1.45B	2.36B	2.18B	2.15B	1.78B	2.03B	1.94B	1.61B	1.44B	1.8B	1.67B	1.64B	1.56B	1.32B	1.76B	2.35B	2.88B	2.33B	2.49B	1.35B	2.04B
Net Income	920M	928M	1.08B	1.78B	1.64B	1.78B	1.33B	9.23B	1.65B	1.3B	1.23B	1.59B	1.44B	1.38B	1.32B	1.03B	1.44B	2.02B	2.45B	1.99B	2.1B	1.19B	1.79B
Selling & General & Admin	4.2B	3.98B	3.26B	3.13B	3.1B	3.09B	3.05B	2.88B	2.9B	2.92B	2.95B	2.7B	2.7B	2.72B	2.75B	2.84B	2.73B	2.76B	2.79B	3B	2.77B	2.72B	2.78B
Research & Development	908M	882M	756M	735M	785M	732M	703M	728M	713M	697M	683M	690M	661M	710M	654M	691M	780M	684M	697M	758M	672M	654M	654M
Other Expenses	841M	658M	422M	422M	420M	411M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	5.95B	5.52B	4.44B	4.29B	4.31B	4.24B	3.76B	3.61B	3.61B	3.62B	3.64B	3.39B	3.36B	3.43B	3.41B	3.53B	3.51B	3.44B	3.48B	3.76B	3.44B	3.38B	3.44B
Interest Expense	297M	299M	174M	120M	44M	121M	134M	152M	166M	168M	117M	235M	148M	153M	162M	164M	56M	85M	10M	89M	119M	136M	66M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	11.54B	10.81B	9.32B	9.21B	9.31B	9.09B	8.67B	8.98B	8.82B	8.69B	8.58B	8.38B	8.47B	8.47B	8.35B	8.65B	8.71B	8.92B	9.01B	9.02B	8.31B	8.23B	8.32B
Income Tax Expense	311M	596M	372M	582M	536M	371M	453M	-7.2B	294M	305M	211M	201M	235M	261M	244M	287M	323M	334M	429M	338M	393M	159M	250M
Shares Outstanding (Basic)	1.74B	1.74B	1.75B	1.75B	1.75B	1.74B	1.75B	1.73B	1.73B	1.73B	1.73B	1.73B	1.74B	1.74B	1.74B	1.74B	1.74B	1.75B	1.75B	1.76B	1.77B	1.77B	1.78B
Shares Outstanding (Diluted)	1.74B	1.74B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.75B	1.76B	1.77B	1.78B	1.78B	1.79B	1.79B	1.79B
EPS (Basic)	0.53	0.53	0.62	1.02	0.94	1.02	0.76	5.33	0.95	0.75	0.71	0.92	0.83	0.79	0.76	0.59	0.82	1.15	1.40	1.13	1.19	0.67	1.01
EPS (Diluted)	0.53	0.53	0.62	1.02	0.94	1.01	0.76	5.27	0.94	0.74	0.70	0.91	0.82	0.78	0.75	0.59	0.81	1.14	1.38	1.12	1.17	0.66	1
EBITDA	1.48B	2.8B	2.25B	3.19B	3.09B	3.05B	2.67B	2.99B	2.91B	2.58B	2.36B	2.84B	2.64B	2.59B	2.53B	2.29B	2.63B	3.26B	3.71B	3.3B	3.46B	2.36B	3.04B
EBIT	1.48B	1.78B	1.52B	2.4B	2.3B	2.27B	1.91B	2.18B	2.11B	1.78B	1.55B	2.03B	1.82B	1.79B	1.72B	1.48B	1.81B	2.44B	2.89B	2.42B	2.61B	1.48B	2.11B
Depreciation & Amortization	n/a	1.01B	730M	792M	791M	777M	756M	807M	801M	805M	805M	813M	824M	800M	806M	807M	815M	822M	823M	883M	847M	874M	934M